Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment

Mise à jour : Il y a 4 ans
Référence : NCT01336751

Femme et Homme

Extrait

Study Primary Objectives: To compare glycemic control, as measured by hemoglobin A1c (A1C), between insulin glargine and 75% insulin lispro protamine suspension/25% insulin lispro as add-on therapies in subjects who failed oral combination therapy with sulfonylurea and metformin. Study Secondary Objectives : To compare the following measures between subjects receiving insulin glargine or 75% insulin lispro protamine suspension/25% insulin lispro: - Incidence of hypoglycemia - Change in weight - Change in serum lipid profile - Percentage of subjects achieving A1C levels ≤7%


Critère d'inclusion

  • Diabetes Mellitus, Type 2

Liens